As global interest in healthy aging, cellular energy, and longevity nutrition continues to grow, ACC Biotech is proud to announce that we are now an authorized distributor of Uthever® NMN (β-Nicotinamide Mononucleotide). Through this partnership, ACC Biotech will introduce clinically supported, high-purity NMN ingredients to nutraceutical and functional health product markets.
Uthever® NMN is a high-purity (≥99%) β-NMN ingredient developed and manufactured by EffePharm, a globally recognized biotechnology company. NMN is a direct precursor of NAD⁺ (Nicotinamide Adenine Dinucleotide), a vital coenzyme involved in cellular energy production, DNA repair, and metabolic regulation.
As NAD⁺ levels naturally decline with age, NMN supplementation has gained attention for its potential role in supporting cellular vitality and healthy aging. Uthever® NMN is one of the few NMN brands supported by human clinical studies, earning strong recognition in the global nutraceutical industry.
As an authorized distributor of Uthever® NMN, ACC Biotech provides more than ingredient supply. We combine premium raw materials with our expertise in OEM/ODM manufacturing, formulation development, and regulatory support, offering comprehensive solutions such as:
Our mission is to help brands efficiently enter the premium NMN market with scientifically backed, high-quality products.
Uthever® represents a benchmark in NMN ingredient quality, while ACC Biotech serves as a trusted partner bridging science, manufacturing, and market application. Together, we aim to deliver reliable, evidence-based NAD⁺ solutions that meet the evolving demands of modern health consumers.
📩 Contact ACC Biotech to learn more about Uthever® NMN distribution and product development opportunities.
